HR 238 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Healthy Technology Act of 2025
To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.
Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence and machine learning technologies to qualify as "practitioners" eligible to prescribe drugs. For an AI or machine learning technology to prescribe drugs, it must be both authorized by the state where it operates to prescribe the specific drug and approved, cleared, or authorized by the Food and Drug Administration through established FDA approval pathways. The bill clarifies the eligibility of AI and machine learning technologies under existing federal drug prescription requirements.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
Money behind the sponsor
Top reported contributors to David Schweikert’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $273,533
- CEO $16,700
- STENSON TAMADDON $13,700
- OPTIMA FINANCIAL GROUP $13,600
- BRODIE GENERATIONAL CAPITAL PARTNERS $13,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for David Schweikert → · Outside spending →
Actions (2)
- Jan 7, 2025 Referred to the House Committee on Energy and Commerce. · house
- Jan 7, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
January 7, 2025
Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Healthy Technology Act of 2025”.
SEC. 2. PRESCRIPTION OF DRUGS BY ARTIFICIAL INTELLIGENCE OR MACHINE LEARNING TECHNOLOGIES.
Section 503(b) of Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) is amended by adding at the end the following:
“(6) In this subsection, the term ‘practitioner licensed by law to administer such drug’ includes artificial intelligence and machine learning technology that are—
“(A) authorized pursuant to a statute of the State involved to prescribe the drug involved; and
“(B) approved, cleared, or authorized under section 510(k), 513, 515, or 564.”. <all>
Comments